Sinopsis
New and exciting data presented each day during the conference and address the potential impact on current clinical practice.
Episodios
-
![Jacqueline C. Barrientos, MD, MS: CLL: Sequencing Monotherapy vs. Combination Therapy]()
Jacqueline C. Barrientos, MD, MS: CLL: Sequencing Monotherapy vs. Combination Therapy
30/04/2019 Duración: 21minWebcast: CLL in the Era of Targeted Therapy: Next Steps in Personalizing Management to Achieve Cure
-
![Richard R. Furman, MD: Novel Treatment Options in CLL]()
Richard R. Furman, MD: Novel Treatment Options in CLL
30/04/2019 Duración: 27minWebcast: CLL in the Era of Targeted Therapy: Next Steps in Personalizing Management to Achieve Cure
-
![Thomas G. Martin, MD: Debate: Is MRD Ready for Prime Time in Myeloma? - No]()
Thomas G. Martin, MD: Debate: Is MRD Ready for Prime Time in Myeloma? - No
30/04/2019 Duración: 10minWebcast: Minimal Residual Disease (MRD) Testing in Multiple Myeloma
-
![Prashant Kapoor, MD: Debate: Is MRD Ready for Prime Time in Myeloma? - Yes]()
Prashant Kapoor, MD: Debate: Is MRD Ready for Prime Time in Myeloma? - Yes
30/04/2019 Duración: 21minWebcast: Minimal Residual Disease (MRD) Testing in Multiple Myeloma
-
![Noopur Raje, MD: Multiple Myeloma: Maintenance Therapy Update]()
Noopur Raje, MD: Multiple Myeloma: Maintenance Therapy Update
30/04/2019 Duración: 21minWebcast: Updates on Treatment Approaches Across the Multiple Myeloma Spectrum
-
![Jonathan L. Kaufman, MD: Multiple Myeloma: Frontline Therapy Updates]()
Jonathan L. Kaufman, MD: Multiple Myeloma: Frontline Therapy Updates
30/04/2019 Duración: 24minWebcast: Updates on Treatment Approaches Across the Multiple Myeloma Spectrum
-
![Thomas G. Martin, MD: Emerging Immunotherapies in Multiple Myeloma]()
Thomas G. Martin, MD: Emerging Immunotherapies in Multiple Myeloma
30/04/2019 Duración: 19minWebcast: Updates on Treatment Approaches Across the Multiple Myeloma Spectrum
-
![Saad Z. Usmani, MD, FACP: Novel Small Molecule Inhibitors in Multiple Myeloma]()
Saad Z. Usmani, MD, FACP: Novel Small Molecule Inhibitors in Multiple Myeloma
30/04/2019 Duración: 14minWebcast: Updates on Treatment Approaches Across the Multiple Myeloma Spectrum
-
![Optimizing Outcomes by Assessing the Evidence: Placental Based Allografts - Dennis P. Orgill, MD, PhD]()
Optimizing Outcomes by Assessing the Evidence: Placental Based Allografts - Dennis P. Orgill, MD, PhD
29/04/2019 Duración: 49minDr. Dennis P. Orgill outlines treatment strategies based on clinical evidence supporting the application of placental based allografts in chronic wound care.
-
![How Science Can Guide Practice: Placental Based Allografts - Gregory Schultz, PhD]()
How Science Can Guide Practice: Placental Based Allografts - Gregory Schultz, PhD
29/04/2019 Duración: 59minDr. Gregory Schultz reviews the molecular and cellular imbalances that disrupt dynamic reciprocity communication between wound cells and the extracellular matrix (ECM) in chronic wounds, and explains how the unique properties of placental based allografts help to restore dynamic reciprocity and stimulate healing.
-
![Placental Based Allografts: From Womb to Wound - Vincent W. Li, MD, MBA]()
Placental Based Allografts: From Womb to Wound - Vincent W. Li, MD, MBA
29/04/2019 Duración: 52minDr. Vincent W. Li reviews the biology of placental based allografts and the components relevant to wound healing, regeneration, and tissue repair.
-
![Innovations in Orthopedic Solutions: Evaluating the use of Decellularized Dermal Allografts in Improving Patients Outcomes - Robert F. Hines, MD and Vytautas M. Ringus, MD]()
Innovations in Orthopedic Solutions: Evaluating the use of Decellularized Dermal Allografts in Improving Patients Outcomes - Robert F. Hines, MD and Vytautas M. Ringus, MD
29/04/2019 Duración: 52minThis series of case studies examines clinical outcomes surrounding reduction in pain and the use of narcotics when using intact extracellular matrix versus other treatment options.
-
![Advancing Multiple Sclerosis Treatment and Outcomes: Navigating Access, Adherence, and Site of Care Obstacles - Jeffrey D. Dunn, PharmD, MBA and Clyde E. Markowitz, MD]()
Advancing Multiple Sclerosis Treatment and Outcomes: Navigating Access, Adherence, and Site of Care Obstacles - Jeffrey D. Dunn, PharmD, MBA and Clyde E. Markowitz, MD
29/04/2019 Duración: 01h02minHear about access, adherence, and site of care issues that hinder optimal MS treatment, and learn best practices to integrate recently-approved DMTs, guideline updates, and clinical/pharmacoeconomic data into value-based benefit design and formulary discussions.
-
![Novel DOAC Reversal Strategies: Update on Best Practices - Mark A. Munger, PharmD, FCCP, FACC, FHFSA, Randolph V. Fugit, PharmD, BCPS, and Paul P. Dobesh, PharmD, FCCP, BCPS, BCCP]()
Novel DOAC Reversal Strategies: Update on Best Practices - Mark A. Munger, PharmD, FCCP, FACC, FHFSA, Randolph V. Fugit, PharmD, BCPS, and Paul P. Dobesh, PharmD, FCCP, BCPS, BCCP
29/04/2019 Duración: 01h01minLearn about the mechanisms of action and safety/efficacy data for currently-approved DOAC reversal agents, and gain insight into comprehensive care strategies that facilitate multidisciplinary management of patients at risk for DOAC-related bleeding.
-
![Robert L. Coleman, MD, Laura Alwan, PharmD, Judith A. Smith, PharmD, Casey Williams, PharmD: Practical Prescribing and Medication Management of PARP Inhibitor Therapy for Ovarian Cancer]()
Robert L. Coleman, MD, Laura Alwan, PharmD, Judith A. Smith, PharmD, Casey Williams, PharmD: Practical Prescribing and Medication Management of PARP Inhibitor Therapy for Ovarian Cancer
03/04/2019 Duración: 50minWebcast: Practical Prescribing and Medication Management of PARP Inhibitor Therapy for Ovarian Cancer
-
![David P. Steensma, MD and Ilene C. Weitz, MD: Real-World Evidence for ITP Treatment]()
David P. Steensma, MD and Ilene C. Weitz, MD: Real-World Evidence for ITP Treatment
31/03/2019 Duración: 25minKey Insights: Real-World Evidence for ITP Treatment
-
![Bruce E. Sands, MD, MS, FACG: Science of New and Emerging IBD Therapies]()
Bruce E. Sands, MD, MS, FACG: Science of New and Emerging IBD Therapies
30/12/2018 Duración: 22minWebcast: The Future of IBD Management: New Targets, Therapies, and Personalized Approaches
-
![Brian G. Feagan, MD, FACG: The Future of IBD Management: New Targets, Therapies, and Personalized Approaches]()
Brian G. Feagan, MD, FACG: The Future of IBD Management: New Targets, Therapies, and Personalized Approaches
30/12/2018 Duración: 20minWebcast: The Future of IBD Management: New Targets, Therapies, and Personalized Approaches
-
![David Binion, MD, FACG, Francis A. Farraye, MD, MSc, FACG, and Constantine Tsigrelis, MD: C. Difficile in IBD: Faculty Discussion and Case Studies]()
David Binion, MD, FACG, Francis A. Farraye, MD, MSc, FACG, and Constantine Tsigrelis, MD: C. Difficile in IBD: Faculty Discussion and Case Studies
22/12/2018 Duración: 18minWebcast: Addressing the Challenges of C difficile Infection (CDI) in IBD: Strategies for Effective Prevention and Treatment
-
![Constantine Tsigrelis, MD: Treatment and/or Prevention or Recurrence of CDI]()
Constantine Tsigrelis, MD: Treatment and/or Prevention or Recurrence of CDI
22/12/2018 Duración: 31minWebcast: Addressing the Challenges of C difficile Infection (CDI) in IBD: Strategies for Effective Prevention and Treatment
